Introduction
The vast majority of the human genome does not encode protein and within the genome are large gene-free tracts called gene deserts. These are of increasing interest to developmental biologists and in contradiction to the use of the phrase 'gene desert', these are not necessarily regions devoid of function but rather may contain a large amount of transcriptional regulatory information. In fact, a subset of gene deserts, most often those associated with highly regulated genes controlling developmental processes, are distinguished by composition. Highly conserved sequence elements that are found in multiple vertebrate species are scattered within this subset of gene deserts [1] , and these were initially considered candidates as gene enhancers. With the recent publication of the ENCODE project, we are gaining insights into the function of this intergenic DNA (for an overview see [2] ). One role of ENCODE was to assign genetic and epigenetic signatures to enhancers and other long-range gene regulators to identify common features to help understand their regulatory activity, and to highlight the potential genomic positions of novel regulatory elements. However, despite these genome wide approaches, the analysis of single developmental genes as paradigms for long-range control is of continuing value in attempts to understand long-range regulatory activity. One such example of long-range control is that of the Shh gene [3] [4] [5] [6] . This gene is expressed in a large number of developing tissues and as a result is under the influence of a number of enhancers, many of which have been identified. Thus, the genomic landscape associated with Shh represents a good model for investigating the level of control required by a typical developmental gene. Here, we discuss the role of Shh during limb development and its participation in a spectrum of limb abnormalities that are associated with the alteration of its long-range regulatory activity.
Structure of the Shh gene
The 5 0 end of the Shh gene is juxtaposed to a long gene desert of about 750 kb in the mouse from which follows a gene-dense region of the genome (figure 1). Cis-regulators that contribute to the complex temporal and spatial pattern of Shh are located within the Shh gene, throughout the gene desert [3, 4] and & 2013 The Author(s) Published by the Royal Society. All rights reserved. interestingly, spilling over into the next two nearest genes (called Rnf32 and Lmbr1). In all, the known cis-regulators extend over 800 kb of DNA in mouse and approximately 1 Mb in human [5, 6] . The position of six neural enhancers start inside the Shh gene and extend to over 400 kb at the 5 0 end, whereas three epithelial enhancers that direct expression to the pharyngeal, lung and gut endodermal linings reside further 5 0 , and cluster near the Rnf32 gene. The furthest regulator, called the ZRS (also called MFCS1 [7] ), lies inside intron 5 of the Lmbr1 gene.
Our interest in Shh gene regulation stems from work investigating the genetic basis of limb abnormalities and particularly those that affect the pattern of skeletal elements that compose our hands and feet. We showed the association of a condition called preaxial polydactyly with mutations in the highly conserved ZRS element [5, 8] . The ZRS regulates expression of Shh in the developing limb bud, within the mesenchyme at the posterior margin. SHH acts as a morphogen and is secreted from a region of the posterior mesenchyme, called the zone of polarizing activity, patterning the digits in a posterior to anterior direction [5, 8, 9] . Thus, the focused expression pattern is crucial for regulating the number of digits and for specifying digit identity. If this precise regulation is altered then the patterning of the limb is compromised.
Evolution of Shh expression in the limb
The ZRS is conserved in a number of vertebrate species including the fishes [5, 7] . For example, comparison of the mouse sequence with that of the coelacanth (Latimeria chalumnae) is striking and shows approximately 75 per cent identity (unpublished data). The ZRS is also found in the Chondrichthyes (sharks and rays) genome [10] , and Shh is expressed in the posterior domain of the developing shark fin. In both of these classes of fish, the relative genomic location of the ZRS is the same as in mammals, with ZRS sitting inside the Lmbr1 gene. In an analysis to establish the activity of the fish enhancer, the conserved ZRS sequence was isolated from the Fugu (pufferfish) genome and attached to a reporter gene for analysis in transgenic mouse embryos. The fish regulator was capable of directing specific expression to the appropriate site at the posterior margin of the developing limb bud [5] . The deep conservation of the ZRS for over 400 Myr of evolution suggests that exact sequence is important for function and that the set of factors that bind and regulate the ZRS are similar in fishes as well as mammals. The skeletal elements that compose the bones of the hands and feet, the carpals/tarsals, metacarpals/metatarsals and phalanges, appeared to arise from a series of transformations that eventually resulted in a novel rstb.royalsocietypublishing.org Phil Trans R Soc B 368: 20120357 structure, the handplate. Within this evolutionary time frame, the ZRS initially regulated expression of Shh in the fin and subsequently, this regulatory network was co-opted in the tetrapods for a function to specify digits in the autopod.
Regulatory mutations cause congenital abnormalities
Shh is a model for genes that are regulated by long-distance enhancers and from a genetic perspective, understanding mutational mechanisms that disrupt this genomic configuration will aid in understanding both normal regulation and processes that underlie congenital abnormalities. Chromosomal translocations that disrupt the regulatory information or cause position affects are well known for SHH [11] , as well as for many other genes [12] . These SHH chromosomal lesions usually result in holoprosencephaly; however, we recently reported a patient with additional malformations displaying severe syndactyly (fusion of the digits) of the hands and feet. An intrachromosomal inversion was identified which interrupts the normal regulatory landscape of the SHH gene [13] . However, the limb defects were not owing to the loss of SHH regulatory information, but rather the influence of newly juxtaposed enhancers.
One of the enhancers adopted in this chromosomal rearrangement displayed limb-specific activity in mouse transgenics experiments. This enhancer directs expression broadly throughout the limb bud and additionally maintains expression to late stages of limb development. Further, a mouse transgenic model was developed in which this enhancer was used to drive Shh expression and the novel spatio-temporal pattern of Shh expression directed by this enhancer caused syndactyly in mouse embryos and is, therefore, most likely responsible for the severe syndactyly found in this patient. Of further interest is the large number of regulatory mutations that directly affect the activity of the ZRS and result in a spectrum of skeletal limb abnormalities [14] . Perhaps contrary to expectations, the mutations that reside in this regulatory element do not just lower or raise the expression levels of the SHH/Shh gene but effect spatial and temporal changes in limb expression, and these changes underlie the abnormal phenotype. In addition, the ZRS mutations show an interesting genotypephenotype correlation leading to distinct clinical classifications of the limb malformations; although, these display an overlapping spectrum of digital abnormalities. These are preaxial polydactyly type 2 (PPD2 which includes isolated triphalangial thumb), triphalangial thumb-polysyndactyly syndrome (TPTPS), syndactyly type IV (SD4) and Werner mesomelic syndrome (WMS). As these defects stem from ZRS mutations, Wieczorek et al [15] suggested that these limb defects be collectively referred to as 'ZRS-associated syndromes'.
Initially, only point mutations were identified in the ZRS in patients with preaxial polydactyly [8, [15] [16] [17] [18] [19] [20] [21] [22] [23] , however, recent developments have added to the mutation spectrum. A 13 bp insertion was found in a Swedish family with limb defects ( [24] ; figure 2a). In addition, a number of reports, particularly one that reports a large study of Chinese families [25] , showed the occurrence of small intrachromosomal duplications that affect ZRS copy number [15, 26] . Two tandem copies of the ZRS give rise to a spectrum of limb defects with the most severe being polydactyly associated with complete syndactyly (TPTPS and SD4). In a recent review, Klopocki & Mundlos [27] suggest that the Laurin-Sandrow syndrome should be included in the spectrum of defects associated with ZRS duplications associated with severe syndactyly. These patients have additional digits that more closely resemble mirror image duplications with one or two thumbs in the middle of the digital array. Some of these patients display long bone involvement with ulnar and fibular duplications.
Mechanisms that underlie the limb abnormalities
It has been known for well over 40 years, since the classic experiments of Saunders [28] , that digit duplications are induced by transplanting mesenchyme from the posterior margin of the limb bud to the anterior margin during the early stages of development. The inducing tissue was defined as originating in the zone of polarizing activity (ZPA) of the limb bud and later the protein responsible for this activity was identified as SHH. We and others [29 -31] showed that in mouse models for preaxial polydactyly Shh is mis-expressed and, in addition to the normal posterior pattern of expression, is found along the anterior margin; thus recreating by genetic mutation those earlier transplantation experiments. Identification of the point mutations gave a molecular basis for the mis-expression. These mutations provided a clear example of the capacity of regulatory mutations to cause human disease, and in addition showed the disease potential of a single base pair change embedded in a million bases of DNA. However, the mechanism for driving the ectopic expression was not clear, and the genetic evidence suggests that there are multiple means for modifying the expression of a gene. The greater than 20 different point mutations associated with limb defects are scattered over the whole approximately 770 bp of the conserved ZRS sequence and are always located at a highly conserved nucleotide. As most evidence suggests, an enhancer functions as a DNA platform for protein interactions and hence, it is expected that the ZRS mutations would affect the binding of a number of different proteins, with perhaps each mutation influencing the binding of a different transcription factor. A point mutation can effect DNA/protein interactions either by changing the affinity of a binding site or by altering the specificity of the site so a different factor binds. Whatever the molecular input from each mutation, these produce a common outcome which is the ectopic expression of Shh.
In an attempt to examine possible mechanisms, it was shown that two of the ZRS mutations (called the AUS and the AC mutations) result in the change in binding specificity ( [32] ; figure 2a). These mutations create additional sites that supplement five consensus binding sites that already reside in the wild-type ZRS. The sites, which share the sequence AGGAA G / A T, bind members of the ETS family of transcription factors. Previously, it was shown by ChIPseq that the two ETS factors, ETS1 and GABPa, are often found together and when associated with this consensus are usually present in putative enhancers located at a distance from the nearest gene [33] . Accordingly, using ChIP-chip ETS1 and GABPa were shown to bind to the ZRS in the limb bud [32] . To establish the role of these two ETS factors, the five binding sites were systematically disrupted in expression constructs in mouse transgenics [32] . The sites play a role in establishing the expression boundary in the posterior of the limb, and disruption of these sites (particularly sites 1 and 3) resulted in a narrower expression rstb.royalsocietypublishing.org Phil Trans R Soc B 368: 20120357 domain. When the AUS mutation was added to the ZRS creating an additional binding site, the boundary of expression expanded, but in addition, appreciable ectopic expression was detected [32] . Interestingly, the 13 bp insertion mutation in the Swedish family resulting in polydactyly (figure 2a) mentioned above [24] contains an AGGAAGT sequence and may effect ectopic expression by a similar mechanism.
Both ETS1 and GABPa are expressed throughout the distal mesenchyme of the limb bud (figure 2b). In addition, two other closely related ETS transcription factors, ETV4 and ETV5, also bind to two sites within the ZRS. These factors are also expressed throughout the distal mesenchyme of the limb and act to restrict expression of the SHH gene to the posterior margin [34, 35] . Disruption of both of the ETV4/5-binding sites together cause expression in the ectopic domain [32] , so the transgenic data is consistent with genetic data that shows ETV4/5 are involved in repressing ectopic expression and restricting Shh to the anterior boundary. Therefore, the two sets of ETS factors play a role in which the overall outcome is to define the spatial pattern of Shh expression (figure 2b). The broad expression of the Ets1 and Gabpa genes in the limb, together with the ChIP-qPCR data that shows binding of ETS1 at the ZRS in the anterior half of the limb [32] , are consistent with the notion that the addition of one extra binding site is sufficient to override the inhibition of Shh at the ectopic site. rstb.royalsocietypublishing.org Phil Trans R Soc B 368: 20120357
Analysis of the point mutation responsible for the polydactylous mouse DZ [23] defined another mechanism by which a novel binding site causes an abnormal limb phenotype. This point change creates a high-affinity binding site for HnRNP U. Previous data shows that the ZRS must move into the vicinity of the Shh promoter to activate transcription [36] . Binding of HnRNP U was postulated to mediate chromosomal looping required for interaction between the ZRS and the promoter region of the Shh gene. As in the anterior limb domain the Shh gene is primed but inactive, the binding of HnRNP U is sufficient to direct the looping and cause the ectopic expression of Shh.
Perhaps a different molecular mechanism is at play in a condition which has been called WMS [15] . Patients from three unrelated families have mutations at the same position in the ZRS (position 404), and these are either a G . C or G . A change [8, 15] . Each patient presents with a similar and very severe limb phenotype. These patients have polydactyly but also exhibit a short-limb dwarfism that results from hypoplasia of the tibia (severe shortening of the long bone in the legs); transgenic analysis of the G . C change showed an extreme pattern of ectopic expression [8] suggesting that these mutations result in production of a high concentration of SHH perhaps disrupting development of the tibia in addition to the polydactyly. It is not clear how the mutation affects ZRS activity; however, the fact that different nucleotide changes occur in the same position suggest that WMS may result from loss of binding of a particular factor. Several factors other than ETV4/5, such as GLI3 and ALX4 [37] , are known to repress Shh expression in the anterior of the limb and the disrupted binding of one of these or another, as yet unknown, repressor may give the severe phenotype seen.
Triphalangial thumb and the extra digits that constitute PPD2 spectrum result from mis-expression of the SHH gene. However, the question remains as to how SHH is involved in tibial hypoplasia and syndactyly. As stated above, the tibial hypoplasia may be due to high concentrations of SHH in the ectopic domain. Syndactyly, however, is more difficult to explain. Recent analysis that led to mis-expression of Shh in the distal mesenchyme of the limb at later stages of limb bud development (at stages when wild-type expression has turned-off) led to syndactyly in the mouse [13] . In these analyses, the interdigital tissue that normally undergoes programmed cell death persisted. It seems likely that the ZRS duplications that result in the severe forms of TPTPS and SD4 may be affecting both the spatial and temporal pattern of SHH expression. Taken together, these examples suggest several different mechanisms that can alter long-range regulation of the SHH gene.
How does the ZRS operate from such a long distance?
It is not clear how a regulator that resides at a long distance activates the promoter of the target gene or whether there are different classes of enhancers separated by the ability to act over very long genomic distances. In attempting to establish some of the rules that regulate the chromatin dynamics of the large Shh regulatory region, Amano et al. [36] examined the ZRS (MFCS1) and its interactions with its target gene. The extreme distance between regulator and gene makes this an excellent system for measuring intranuclear distances. By measuring physical distances by 3D-FISH (3 dimensional fluorescent in situ hybridization) in the ZPA region of the limb bud, it was demonstrated that the Shh gene and the ZRS showed a significant decrease in their intranuclear distance; whereas, an intermediate sequence in the gene desert did not; data that is indicative of looping. By analysing just those cells actively transcribing Shh, the percentage of cells with a close association of ZRS and the Shh gene increased dramatically. A physical interaction was further confirmed by 3C (chromosome conformation capture). A striking observation from these studies was that only a proportion of ZPA cells were productively transcribing the Shh gene at any one time. However, in the notochord and neural tissue, where expression is associated with enhancers acting at a closer range, the expression of Shh is strong and long-lasting. This led to the suggestion that a different mode of action occurs between short-range and longrange enhancers and may provide a means for regulating levels in different developing tissues. Another observation from this study is that the ZRS appears primed, but inactive, at the anterior margin of the limb bud. We postulate that this poised state is crucial to the ectopic expression that leads to the limb abnormalities and that the regulatory mutations are sufficient to drive the ZRS from this state into an active configuration. A contributing factor to this poised state may be the location of the ZRS inside an actively transcribed gene (the Lmbr1 gene). The activity of a number of putative enhancers have been associated with transcription though the enhancer sequence producing small non-coding RNAs, so-called enhancer RNAs [36, 38] . Hence, transcription through the ZRS may play a role in this priming process. Further studies are required to understand this relationship, and because a number of developmental enhancers reside inside neighbouring active genes, this may be a common mechanism for regulating genes during development.
Conclusions
Long-range regulation of genes is an important process during development. Each regulator has its own unique signature encoded by the sequence resulting in a distinct set of DNAbinding factors. These factors will direct the long-range activity to seek out the appropriate promoter within hundreds of thousands of base pairs, and as a consequence provide the spatial and temporal regulatory information for transcription. By studying individual models for long-range gene expression, we will be able to ask specific questions about transcriptional specificity unique to developmental tissue and stage, and begin to understand what happens when mutations cause the inbuilt precision of the system to break down. 
